Current State of Type 1 Diabetes Immunotherapy: Incremental Advances, Huge Leaps, or More of the Same?

Clinical and Developmental Immunology
doi 10.1155/2011/432016
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Hindawi Limited

Related search

Recent Advances in Management of Type 1 Diabetes

Australian journal of general practice
Medicine
2019English

Recent Advances in Understanding Type 1 Diabetes

F1000Research
GeneticsMolecular BiologyPharmacologyBiochemistryMicrobiology ImmunologyMedicineToxicologyPharmaceutics
2016English

Antigen-Specific Immunotherapy for Type 1 Diabetes: Maximizing the Potential

Diabetes
Internal MedicineEndocrinologyMetabolismDiabetes
2010English

A Future for CD3 Antibodies in Immunotherapy of Type 1 Diabetes

Diabetologia
Internal MedicineEndocrinologyMetabolismDiabetes
2019English

New Approaches to the Immunotherapy of Type 1 Diabetes Mellitus Using Interleukin-27

Advanced Pharmaceutical Bulletin
ToxicologyPharmaceuticsPharmacologyPharmaceutical Science
2015English

Current State of Immunotherapy for Treatment of Glioblastoma

Current Treatment Options in Oncology
OncologyPharmacology
2019English

Interactive Marketing: The New Marketing — Or More of the Same?

Interactive Marketing
2002English

Current Understanding of the Role of Gut Dysbiosis in Type 1 Diabetes

Journal of Diabetes
EndocrinologyMetabolismDiabetes
2019English

GDM: More Diabetes, More Good or More Harm?

BJOG: An International Journal of Obstetrics and Gynaecology
GynecologyObstetrics
2019English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2025 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy